Brind.
  1. Zentek is continuing the commercialization of the ZenGUARD platform and developing the Albany Graphite Project, targeting Canadian purchasers under NI 45-106 rules.
  2. Zentek's board determined on July 12, 2025, not to extend the consulting contract for the ZenGUARD production facility in Guelph.

Health Canada is considering the regulatory classification of ZenGUARD, produced at Zentek's facility in Guelph, Ontario.

1 report, 0 independent Updated Jun 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Health Canada is considering the regulatory classification of ZenGUARD, produced at Zentek's facility in Guelph, Ontario.

Who's involved

What this event is mainly about
Ontario

Keep exploring

Part of

Zentek's board determined on July 12, 2025, not to extend the consulting contract for the ZenGUARD production facility in Guelph. All 1 developments

Within Zentek is continuing the commercialization of the ZenGUARD platform and developing the Albany Graphite Project, targeting Canadian purchasers under NI 45-106 rules.

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet